KÖRPERPERFUSIONSSYSTEM

European patent · EP3618761 · In force

Register entry

Publication number
EP3618761
Application number
EP18720624
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
May 2, 2018
Published
Mar 11, 2020
Granted
Jun 28, 2023
Protection ends at the latest
May 1, 2038
Next annual fee due
May 31, 2027
IPC classes
A61F 2/02 (2006.01)
A61M 1/34 (2006.01)
A61M 1/36 (2006.01)
A61M 5/172 (2006.01)
C12N 5/071 (2010.01)
Priority
EP 17169158 02.05.2017
PCT application
PCT/EP2018/061127 02.05.2018
PCT publication
WO2018/202671 08.11.2018
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jun 1, 2026

    Change

    Published in Swissreg on 01.06.2026

  2. Jun 1, 2025

    Change

    Published in Swissreg on 01.06.2025

  3. Jun 2, 2024

    Change

    Published in Swissreg on 02.06.2024

  4. May 8, 2024

    Change

    Published in Swissreg on 08.05.2024

  5. Dec 6, 2023

    Agent entered

    Representative
    Schmauder & Partner AG, Patent- und Markenanwälte VSP, Zwängiweg 7, 8038 Zürich

    Published in Swissreg on 06.12.2023

  6. Sep 27, 2023

    Owner

    Owner
    SeraIP AG, Alter Postplatz 2, 6370 Stans → SecureCell AG, In der Luberzen 29, 8902 Urdorf

    Published in Swissreg on 27.09.2023

  7. Jun 28, 2023

    Granted

    Published in Swissreg on 28.06.2023

Parties

Holder

SecureCell AG

In der Luberzen 29, 8902 Urdorf

Agent

Schmauder & Partner AG

Patent- und Markenanwälte VSP Zwängiweg 7, 8038 Zürich

Inventor

ANDRETTA, Carlo

8142 Uitikon-Waldegg

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.